Simplex Trading’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $35.6M | Sell |
1,266,685
-224,352
| -15% | -$5.97M | 0.02% | 292 |
|
|
2025
Q4 | $37.1M | Buy |
1,491,037
+194,547
| +15% | +$4.91M | 0.02% | 350 |
|
|
2025
Q3 | $33M | Buy |
1,296,490
+1,262,307
| +3,693% | +$31.2M | 0.02% | 466 |
|
|
2025
Q2 | $828K | Sell |
34,183
-1,582,619
| -98% | -$36.9M | ﹤0.01% | 2974 |
|
|
2025
Q1 | $41M | Buy |
1,616,802
+50,149
| +3% | +$1.31M | 0.03% | 318 |
|
|
2024
Q4 | $41.6M | Buy |
1,566,653
+1,303,687
| +496% | +$35.4M | 0.02% | 362 |
|
|
2024
Q3 | $7.61M | Sell |
262,966
-1,932,294
| -88% | -$56.4M | ﹤0.01% | 1203 |
|
|
2024
Q2 | $61.4M | Sell |
2,195,260
-2,410,725
| -52% | -$66.4M | 0.04% | 257 |
|
|
2024
Q1 | $128M | Buy |
4,605,985
+3,225,864
| +234% | +$89.5M | 0.07% | 136 |
|
|
2023
Q4 | $39.7M | Sell |
1,380,121
-575,573
| -29% | -$17.4M | 0.03% | 417 |
|
|
2023
Q3 | $64.9M | Buy |
1,955,694
+1,430,473
| +272% | +$50.6M | 0.05% | 220 |
|
|
2023
Q2 | $19.3M | Buy |
525,221
+467,052
| +803% | +$18.2M | 0.02% | 590 |
|
|
2023
Q1 | $2.37M | Buy |
58,169
+4,179
| +8% | +$180K | ﹤0.01% | 1802 |
|
|
2022
Q4 | $2.77M | Sell |
53,990
-801,594
| -94% | -$38.4M | ﹤0.01% | 1620 |
|
|
2022
Q3 | $37.4M | Buy |
+855,584
| New | +$41.6M | 0.04% | 322 |
|
|
2022
Q2 | – | Sell |
-130,516
| Closed | -$6.65M | – | 10812 |
|
|
2022
Q1 | $6.76M | Buy |
130,516
+97,654
| +297% | +$5.07M | 0.01% | 1047 |
|
|
2021
Q4 | $1.94M | Sell |
32,862
-36,598
| -53% | -$1.81M | ﹤0.01% | 2078 |
|
|
2021
Q3 | $2.75M | Buy |
69,460
+15,114
| +28% | +$670K | ﹤0.01% | 1769 |
|
|
2021
Q2 | $2.13M | Sell |
54,346
-410,282
| -88% | -$16M | ﹤0.01% | 2078 |
|
|
2021
Q1 | $16.8M | Buy |
+464,628
| New | +$16.5M | 0.03% | 317 |
|
|
2020
Q4 | – | Sell |
-14,900
| Closed | -$547K | – | 8892 |
|
|
2020
Q3 | $518K | Sell |
14,900
-433,397
| -97% | -$15.2M | ﹤0.01% | 2960 |
|
|
2020
Q2 | $13.9M | Buy |
+448,297
| New | +$15.2M | 0.02% | 397 |
|
|
2019
Q4 | – | Sell |
-188,364
| Closed | -$6.71M | – | 7814 |
|
|
2019
Q3 | $6.42M | Sell |
188,364
-734
| -0.4% | -$26.7K | 0.02% | 588 |
|
|
2019
Q2 | $7.77M | Buy |
189,098
+124,586
| +193% | +$4.95M | 0.02% | 490 |
|
|
2019
Q1 | $2.6M | Buy |
64,512
+64,196
| +20,315% | +$2.57M | 0.01% | 1141 |
|
|
2018
Q4 | $13K | Sell |
316
-122,756
| -100% | -$5.1M | ﹤0.01% | 5677 |
|
|
2018
Q3 | $5.14M | Buy |
+123,072
| New | +$4.74M | 0.02% | 606 |
|
|
2018
Q2 | – | Sell |
-135,875
| Closed | -$4.64M | – | 7762 |
|
|
2018
Q1 | $4.58M | Buy |
+135,875
| New | +$4.67M | 0.2% | 88 |
|
|
2017
Q3 | – | Sell |
-167,179
| Closed | -$5.37M | – | 6447 |
|
|
2017
Q2 | $5.33M | Buy |
167,179
+102,384
| +158% | +$3.23M | 0.23% | 68 |
|
|
2017
Q1 | $2.1M | Buy |
+64,795
| New | +$2.04M | 0.09% | 198 |
|
|
2016
Q2 | – | Sell |
-32,660
| Closed | -$1.04M | – | 6308 |
|
|
2016
Q1 | $918K | Sell |
32,660
-192,774
| -86% | -$5.51M | 0.07% | 244 |
|
|
2015
Q4 | $6.9M | Buy |
225,434
+221,003
| +4,988% | +$6.95M | 0.54% | 31 |
|
|
2015
Q3 | $132K | Sell |
4,431
-19,732
| -82% | -$633K | 0.01% | 1196 |
|
|
2015
Q2 | $768K | Buy |
+24,163
| New | +$788K | 0.06% | 269 |
|
Other funds holding PFE
VCM
VPM
Simplex Trading's PFE Position: Q1 2026 in Review
Simplex Trading reduced its Pfizer (PFE) stake by 15% in Q1 2026, selling an estimated $5.97M and leaving 1,266,685 shares worth $35.6M. The position accounts for 0.02% of the portfolio, ranked #292.
Simplex Trading first reported a position in PFE in Q2 2015 and has held it in 34 quarters since. The position peaked at $128M in Q1 2024. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Simplex Trading held 1,266,685 shares of Pfizer worth $35.6M as of Q1 2026.
- Simplex Trading sold 224,352 Pfizer shares in Q1 2026, an estimated $5.97M.
- Pfizer made up 0.02% of Simplex Trading's portfolio in Q1 2026, its #292 holding.
- Simplex Trading first reported a position in Pfizer in Q2 2015 and has held it in 34 quarters since.
- Simplex Trading's Pfizer position peaked at $128M in Q1 2024.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.